Corporate Office HQ

Medical

Henry Schein Corporate Office

Henry Schein Inc. is a distributor of health care products.

The company was founded in 1932 when Henry Schein opened a pharmacy in Queens, New York.

In the 1950’s Schein changed the focus of his business from consumer based to office-based practitioners.

In the 1990’s the company began to expand internationally with offices in Spain, Holland and the U.K.

Today Henry Schein is a leading global distributor of dental supplies, equipment and pharmaceuticals. The company also supplies doctors’ offices and veterinarians with diagnostic kits, surgical tools, drugs, vaccines and animal health products. In addition, Henry Schein provides software, financing, and repair services.

Henry Schein is publicly traded on the NASDAQ under the ticker symbol HSIC, is a member of the S&P 500, is #339 in the Fortune 500, has 17,000 employees, and had $9.92 billion in revenue in 2013.

Henry Schein inc.

Henry Schein Inc. is a distributor of health care products.

The company was founded in 1932 when Henry Schein opened a pharmacy in Queens, New York.

In the 1950’s Schein changed the focus of his business from consumer based to office-based practitioners.

History

In the 1990’s the company began to expand internationally with offices in Spain, Holland and the U.K.

Today Henry Schein is a leading global distributor of dental supplies, equipment and pharmaceuticals. The company also supplies doctors’ offices and veterinarians with diagnostic kits, surgical tools, drugs, vaccines and animal health products. In addition, Henry Schein provides software, financing, and repair services.

Henry Schein is publicly traded on the NASDAQ under the ticker symbol HSIC, is a member of the S&P 500, is #339 in the Fortune 500, has 17,000 employees, and had $9.92 billion in revenue in 2013.

Omnicare Corporate Office

Omnicare was founded in 1981 as a healthcare services company. The company began trading publicly two months later.

In 1985 Omnicare began its focus on pharmacy services for long-term facilities.

The company grew steadily through the acquisition of institutional pharmacies and other companies.

Today Omnicare is the country’s largest institutional pharmacy service providor, dispensing drugs to nursing homes and other long-term care facilities in the United States and Canada. The company also provides related consulting and data management services.

Omnicare trades publicly on the New York Stock Exchange under the ticker symbol OCR, is a member of the S&P 500, is #347 in the Fortune 500, has 13,000 employees, and had $6.23 billion in revenue in 2013.

 

Omnicare Inc.

Omnicare was founded in 1981 as a healthcare services company. The company began trading publicly two months later.

In 1985 Omnicare began its focus on pharmacy services for long-term facilities.

The company grew steadily through the acquisition of institutional pharmacies and other companies.

History

Today Omnicare is the country’s largest institutional pharmacy service providor, dispensing drugs to nursing homes and other long-term care facilities in the United States and Canada. The company also provides related consulting and data management services.

Omnicare trades publicly on the New York Stock Exchange under the ticker symbol OCR, is a member of the S&P 500, is #347 in the Fortune 500, has 13,000 employees, and had $6.23 billion in revenue in 2013.

 

WellCare Health Plans Corporate Office

WellCare Health Plans was founded in 1985 in Tampa, Florida.

The company provides managed care administrative services to health care programs funded by the government, including Medicaid, Medicare and State Children’s Health Insurance Programs, under the brands Staywell, HealthEase, WellCare, Missouri Care, ‘Ohana, and Harmony.

WellCare works with over 90,000 physicians and provides services to 2.8 million members.

In January 2020, Centene Corporation acquired WellCare for an unknown amount. WellCare will be removed from the NYSE as of January 23, 2020. 

WellCare Health Plans has 14,000 employees, and had $17.08 billion in revenue in 2017. The company maintains a corporate office in Tampa, Florida.

WellCare Health Plans

WellCare Health Plans was founded in 1985 in Tampa, Florida.

The company provides managed care administrative services to health care programs funded by the government, including Medicaid, Medicare and State Children’s Health Insurance Programs, under the brands Staywell, HealthEase, WellCare, Missouri Care, ‘Ohana, and Harmony.

History

WellCare works with over 90,000 physicians and provides services to 2.8 million members.

In January 2020, Centene Corporation acquired WellCare for an unknown amount. WellCare will be removed from the NYSE as of January 23, 2020. 

WellCare Health Plans has 14,000 employees, and had $17.08 billion in revenue in 2017. The company maintains a corporate office in Tampa, Florida.

Gilead Sciences Corporate Office

Gilead Sciences was founded by Michael Riordan in 1987 with a $2 million investment from Menlo Ventures.

The company focused on making small strands of DNA to assess the potential of gene therapy. Gilead Sciences developed small molecule antiviral therapeutics in 1991, one of which was tenofivir, which became one of the most widely-used anti AIDS drugs.

Donald Rumsfield became a board member at Gilead Sciences in 1988, and was the chairman in 2001 when he was stepped down to become the U.S. Secretary of Defense. At the time he owned between $5 million and $25 million of Gilead stock.

Today Gilead Sciences is a biotech company with treatments for hepatitis, HIV, infections related to AIDS, cardiovascular drugs, and respiratory and ophthalmic medicines.

Gilead Sciences is traded publicly on the NASDAQ under the ticker symbol GILD, is a member of the S&P 500, is #324 in the Fortune 500, has 6,100 employees, and had $17.44 billion in revenue in 2013.

 

Gilead Sciences

Gilead Sciences was founded by Michael Riordan in 1987 with a $2 million investment from Menlo Ventures.

The company focused on making small strands of DNA to assess the potential of gene therapy. Gilead Sciences developed small molecule antiviral therapeutics in 1991, one of which was tenofivir, which became one of the most widely-used anti AIDS drugs.

Donald Rumsfield became a board member at Gilead Sciences in 1988, and was the chairman in 2001 when he was stepped down to become the U.S. Secretary of Defense. At the time he owned between $5 million and $25 million of Gilead stock.

History

Today Gilead Sciences is a biotech company with treatments for hepatitis, HIV, infections related to AIDS, cardiovascular drugs, and respiratory and ophthalmic medicines.

Gilead Sciences is traded publicly on the NASDAQ under the ticker symbol GILD, is a member of the S&P 500, is #324 in the Fortune 500, has 6,100 employees, and had $17.44 billion in revenue in 2013.

 

Becton, Dickinson and Company Corporate Office

Becton, Dickinson and Company, known as BD, was founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson and its first product was a Luer-all-glass syringe.

In 1924 the company manufactured its first syringe designed for insulin injection.

In 1947 BD developed the Evacutainer- a device that drew blood through a needle into a test tube by vacuum.

The company grew through acquisition and international expansion. By the 1950’s BD was operating in Canada, Mexico, France, and Brazil.

Today Becton, Dickinson and Company is one of the top global manufacturers of syringes and other injection devices. The company also manufactures catheters, prefillable drug delivery systems, self-injection devices for diabetes patients, anesthesia trays, and sharps disposable systems, among others.

Becton, Dickinson and Company trades publicly on the New York Stock Exchange under the ticker symbol BDX, is a member of the S&P 500, is #312 in the Fortune 500, has 30,000 employees, and had $8.29 billion in revenue in 2013.

Becton, Dickinson and Company

Becton, Dickinson and Company, known as BD, was founded in 1897 by Maxwell W. Becton and Fairleigh S. Dickinson and its first product was a Luer-all-glass syringe.

In 1924 the company manufactured its first syringe designed for insulin injection.

In 1947 BD developed the Evacutainer- a device that drew blood through a needle into a test tube by vacuum.

History

The company grew through acquisition and international expansion. By the 1950’s BD was operating in Canada, Mexico, France, and Brazil.

Today Becton, Dickinson and Company is one of the top global manufacturers of syringes and other injection devices. The company also manufactures catheters, prefillable drug delivery systems, self-injection devices for diabetes patients, anesthesia trays, and sharps disposable systems, among others.

Becton, Dickinson and Company trades publicly on the New York Stock Exchange under the ticker symbol BDX, is a member of the S&P 500, is #312 in the Fortune 500, has 30,000 employees, and had $8.29 billion in revenue in 2013.